A limited number of correlative studies has shown aberrant SYCP2 expression in breast and papillomavirus-positive oropharyngeal carcinoma20,21, while mechanisms, potential clinical, and therapeutic relevance of SYCP2 in cancers have not been well defined. Here, SYCP2 is linked to cancer.